Lidocaine Patch 5%: A Viewpoint by Bradley S. Galer

Galer, B.S.
February 2000
Drugs;Feb2000, Vol. 59 Issue 2, p250
Academic Journal
Discusses the use of lidocaine patch 5% for postherpetic neuralgia therapy. Reasons of neuropathic pain scientists for using lidocaine patch 5%; Details on treatment for postherpetic neuralgia prior to lidocaine patch 5%; Benefits of lidocaine patch 5%.


Related Articles

  • Lidocaine Patch 5%: A Viewpoint by Andrew P. Baranowski. Baranowski, A.P. // Drugs;Feb2000, Vol. 59 Issue 2, p250 

    Discusses the use of lidocaine patch 5% in the treatment of postherpetic neuralgia. Prevalence of postherpetic neuralgia; Mechanism of action; Symptoms of postherpetic neuralgia.

  • Lidocaine Patch 5%. Comer, A.M.; Lamb, H.M. // Drugs;Feb2000, Vol. 59 Issue 2, p245 

    â–´ Lidocaine patch 5% comprises a soft, stretchy adhesive patch (10 by 14cm) containing 5% lidocaine (700mg) for the topical treatment of pain associated with postherpetic neuralgia (PHN). â–´ Lidocaine provides analgesic relief by blocking neuronal sodium channels. â–´ Systemic...

  • Neuropathic Pain. Bush, Nancy Jo; Smith, Lisa Hartkopf // Oncology Nursing Forum;Apr2002, Vol. 29 Issue 3, p1 

    Presents solutions to the problem regarding the management of neuropathic pain. Difference between neuropathic pain and nociceptive pain; Role of amitriptyline, lidocaine patches, opioids and dexamethasone in the management of postherpetic neuralgia (PHN); Nonpharmacologic interventions that...

  • Lidocaine.  // Reactions Weekly;Nov2014, Vol. 1527 Issue 1, p140 

    The article presents the case of a 45-year-old man, who developed transient brainstem anaesthesia after treatment with diagnostic local anaesthetic block with lidocaine for trigeminal neuralgia.

  • Versatis vs pregabalin for postherpetic neuralgia.  // PharmacoEconomics & Outcomes News;1/23/2010, Issue 595, p6 

    The article discusses research on the cost effectiveness of 5% lidocaine medicated plaster compared with pregabalin for treating postherpetic neuralgia, that references a study by M. Richie and colleagues published in a 2010 issue of "Clinical Drug Investigation."

  • Managing Post-Herpetic Neuralgia. Shovlin, Joseph P. // Review of Optometry;12/15/2004, Vol. 141 Issue 12, p63 

    The article presents answers to queries on managing post-herpetic neuralgia. In reply to a question, Dr. H.S. Ghazi- Birry, 6D of the Southern College of Optometry in Memphis, Pennsylvania, says to start with 300mg of the anti-epileptic Neurontin once a day on day one, twice a day on day two and...

  • Lidocaine patch available for relief of pain associated with postherpetic neuralgia. Maudlin, Robert K. // Modern Medicine;Nov99, Vol. 67 Issue 11, p59 

    Provides information on Lidocaine 5% patch used for the treatment of postherpetic neuralgia. Composition of the patch; How the patch is used; Localized adverse reactions.

  • Lidocaine patch approved for postherpetic neuralgia. Maudlin, Robert K. // Modern Medicine;Jun99, Vol. 67 Issue 6, p51 

    Reports on the approval made by the United States Food and Drug Administration on a lidocaine patch (Lidoderm) to treat pain associated with postherpetic neuralgia. Components of the patch; When the treatment of herpes zoster should begin.

  • Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia. Zakrzewska, Joanna M // Evidence-Based Dentistry;Sep2007, Vol. 8 Issue 3, p85 

    Data sourcesThe Cochrane Pain, Palliative and Supportive Care Group Trials Register, Cochrane Central Register of Controlled Trials, Medline, Embase, LILACS (Latin American and Caribbean Health Sciences), SIGLE (System for Information on Grey Literature in Europe)(for conference proceedings) and...


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics